Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Cronus Books, Carson City, NV, USA
Hardcover. Zustand: New. * NEW Inside and Out! Clean & Crisp Pages. (E-mail for more info./pics).
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Better World Books, Mishawaka, IN, USA
Erstausgabe
Zustand: Very Good. 1st Edition. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Hardcover. Zustand: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: WorldofBooks, Goring-By-Sea, WS, Vereinigtes Königreich
EUR 9,53
Anzahl: 1 verfügbar
In den WarenkorbHardback. Zustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
Zustand: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Antiquariaat Die Sammlung, Amsterdam Zuidoost, Niederlande
Erstausgabe
Hardcover. Zustand: Fine. 1st Edition. 137 p.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 153,78
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 156,98
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 250 pages. 9.25x7.50x9.25 inches. In Stock.
Zustand: New.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: California Books, Miami, FL, USA
Zustand: New.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 163,88
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, 2025
ISBN 10: 0443274126 ISBN 13: 9780443274121
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 171,03
Anzahl: Mehr als 20 verfügbar
In den WarenkorbPaperback / softback. Zustand: New. New copy - Usually dispatched within 4 working days.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
EUR 183,48
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. The future of mood-disorder research: covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities. Editor(s): Beyer, Chad E.; Stahl, Stephen M. Num Pages: 150 pages, 27 b/w illus. 10 tables. BIC Classification: MMGW. Category: (P) Professional & Vocational. Dimension: 242 x 156 x 62. Weight in Grams: 454. . 2010. New. hardcover. . . . .
Sprache: Englisch
Verlag: Cambridge University Press, GB, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
EUR 202,00
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.
EUR 208,46
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 205,56
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Sprache: Englisch
Verlag: Cambridge University Press CUP, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 150.
EUR 229,05
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Kennys Bookstore, Olney, MD, USA
EUR 229,52
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. The future of mood-disorder research: covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities. Editor(s): Beyer, Chad E.; Stahl, Stephen M. Num Pages: 150 pages, 27 b/w illus. 10 tables. BIC Classification: MMGW. Category: (P) Professional & Vocational. Dimension: 242 x 156 x 62. Weight in Grams: 454. . 2010. New. hardcover. . . . . Books ship from the US and Ireland.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 227,82
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.
Sprache: Englisch
Verlag: Cambridge University Press, GB, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Rarewaves.com UK, London, Vereinigtes Königreich
EUR 191,90
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 301,95
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 137,68
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 167,00
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 150 pages. 9.49x6.30x0.59 inches. In Stock. This item is printed on demand.
Sprache: Englisch
Verlag: Cambridge University Press, Cambridge, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone involved in psychopharmacology development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Sprache: Englisch
Verlag: Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 174,63
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, San Diego, 2025
ISBN 10: 0443274126 ISBN 13: 9780443274121
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
EUR 153,34
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: new. Paperback. Kratom: History, Science and Therapeutic Potential is the first book to address the unregulated, widespread availability of kratom, with its weak opioid and stimulant effects, coupled with limited awareness of it by healthcare professionals. Kratom has great therapeutic utility and medicinal potential, but more study, caution, and possible regulation is needed. It discusses geographical sourcing, historical uses, current worldwide uses, and potential for treatment of other medical conditions. Most exciting for healthcare professionals will be the implications of this substance's potential for treatment of diseases like depression, ADHD, PTSD, and substance-use disorder, particularly opioid use disorder (OUD).Moreover, kratom and its active alkaloid mitragynine are getting remarkable attention at federal and local governments as more than eight million Americans consume this product annually. Yet, the paucity of information for researchers and clinicians is troublesome. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Sprache: Englisch
Verlag: Cambridge University Press, 2011
ISBN 10: 0521760585 ISBN 13: 9780521760584
Anbieter: moluna, Greven, Deutschland
EUR 169,50
Anzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone i.